All Reports Events Blogs Videos
Showing 140 results
  • NEW
    Blog
    Aug. 03, 2026

    In Part 1 of this series, Why the Migration Clock Has Already Started, we explained why Banking, Financial Services and Insurance (BFSI) enterprises cannot wait for a formal mandate to begin their Post-quantum Cryptography (PQC) migration and estimated a roughly US$7 billion spending opportunity across the top…
  • Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • Video
    Feb. 10, 2026

    Everest Group’s PEAK Matrix® Assessment assesses RTSM providers through the lens of buyer impact and delivery capability. In this deep dive, Nisarg Shah, Practice Director, and Kayva Murki, Senior Analyst, analyze the RTSM provider market in…
  • Video
    Feb. 10, 2026

    The PEAK Matrix® Assessment provides a structured evaluation of RTSM providers’ strengths, scale, and differentiation in the market. Nisarg Shah, Practice Director, and Kayva Murki, Senior Analyst, explore the major growth drivers accelerating RTSM adoption. They…
  • Video
    Feb. 10, 2026

    Everest Group’s PEAK Matrix® Assessment evaluates RTSM providers based on market impact and vision & capability. In this video, Nisarg Shah, Practice Director, and Kayva Murki, Senior Analyst, unpack findings from the inaugural RTSM PEAK Matrix®…
  • Provider Compendium
    Dec. 17, 2025

    Life sciences organizations are increasingly prioritizing automation, configurability, and real-time visibility to support modern clinical trial requirements. As adaptive designs, decentralized models, and global multi-protocol studies become more prevalent, the role of Randomization and Trial Supply…
  • PEAK Matrix®
    Nov. 25, 2025

    With global and adaptive clinical trials’ rising complexities, life sciences organizations are increasingly adopting intelligent Randomization and Trial Supply Management (RTSM) platforms to enhance operational efficiency, ensure regulatory compliance, and safeguard patient integrity. RTSM systems have…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • Blog
    Nov. 04, 2025

    In an era of increasingly complex clinical trials, Risk-Based Quality Management (RBQM) has emerged as more than a regulatory mandate, it is a strategic imperative. Traditional monitoring methods, reliant on exhaustive on-site visits and 100% Source…
  • Tech Provider Spotlight
    Oct. 14, 2025

    Clinical trial complexity continues to increase with hybrid study models, diverse data sources, and growing regulatory expectations, making traditional oversight models inadequate. Conventional monitoring approaches reliant on 100% source data verification and frequent on-site visits are…
  • LinkedIn Live
    July 24, 2025

    Watch on LinkedIn Global Capability Centers (GCCs) in India rapidly evolved from cost-efficient service hubs to strategic centers of innovation, product development, and digital transformation for global enterprises. As this evolution accelerated, talent development became a…
  • Provider Compendium
    June 27, 2025

    CTMS platforms centralize and streamline every aspect of a clinical trial – planning, site coordination, patient tracking, budget oversight, document management, and regulatory compliance – into one unified, cloud-based system. The increasing trial complexity, the growing…
  • Viewpoint
    June 27, 2025

    As enterprise technology ecosystems grow increasingly complex and fragmented, legacy SIAM models are reaching their limits. The traditional SIAM function – often reactive, siloed, and under-tooled – has struggled to keep pace with the demands of…
  • Viewpoint
    June 27, 2025

    Clinical trials are becoming more complex due to the adoption of decentralized models, increasing data volumes, and greater regulatory scrutiny. Conventional approaches centered on 100% Source Data Verification (SDV) and uniform on-site monitoring are inefficient, costly,…
  • Provider Compendium
    June 25, 2025

    As enterprises embrace hybrid work and respond to the evolving expectations of multigenerational workforces, rethinking digital workplace strategies has become a strategic priority. Microsoft modern work solutions, such as Microsoft Teams and other Microsoft 365 applications,…
  • Viewpoint
    May 23, 2025

    Despite the global economic downturn, enterprises continue to embrace AI, with generative AI demonstrating strong workplace transformation potential. Segments such as service desks and unified communication and collaboration have significantly advanced, leading to enterprises achieving notable…
  • PEAK Matrix®
    May 14, 2025

    As enterprises embrace hybrid work models and adapt to the evolving needs of a multi-generational workforce, reimagining digital workplace strategies has become essential. With widespread global adoption, Microsoft’s modern work solutions, such as, Microsoft Teams and…
  • May 12, 2025

    Risk-Based Monitoring (RBM), once seen as a breakthrough in clinical trial oversight, now faces challenges in keeping up with the growing complexity and regulatory demands of modern trials.While it brought significant improvements in monitoring efficiency, now…
  • May 12, 2025

    Introduction: The evolving landscapeArtificial Intelligence (AI) is revolutionizing industries, and Private Equity (PE) firms are rapidly adapting to harness its benefits. With record-breaking fundraising and considerable dry powder providing a strong capital base, PE firms are…
  • State of the Market
    May 07, 2025

    The life sciences R&D engine is rapidly digitizing, and clinical development software now sits at its center. This report sizes the global clinical trials technology market at nearly US$6.5 billion for 2025 (8-10% CAGR) and dissects…

Items per page